Health● Low2h ago · Nov 11, 2026, 2:42 AM
Capricor outlines 2027 manufacturing validation as Deramiocel BLA heads toward Nov. 22 PDUFA date
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Capricor has detailed its manufacturing validation plans for 2027 as its Deramiocel BLA approaches a PDUFA date of November 22. This update is important for the company's product development and regulatory timeline.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
1 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Health
Not flagged as developing.
More in Health
Health16m agoStudy: Coffee improves digestion and reduces acidityAsharq Al-Awsat [ar] · Saudi ArabiaHealth18m agoSport against breast cancer: 'Dragon Boat', the millennial specialty born in China that rehabilitates the body and rescues self-esteemInfobae · ArgentinaHealth34m agoWork Performance: A Ritalin capsule and the desire to be a high performerDie Zeit · GermanyHealth48m agoThe inverse path of Málaga's Pascual: the private hospital that has become publicEl Confidencial · Spain